ERC-BELGIUM S.A.
Epitopoietic Research Corporation (ERC-Belgium SA) is a clinical stage emerging Biopharmaceutical Company developing a safe, highly effective approach for the treatment of cancer, particularly cancers of the brain. ERC has built a network of leading neuro-oncologists in several countries in the world, among others in the US and Europe to propel its immunotherapies through clinical development and to market. ERC’s regimen of therapeutic vaccines has shown early promise in patients suffering from recurrent Glioblastoma multiforme (GBM), the deadliest of brain cancers.
ERC-BELGIUM S.A.
Industry:
Biotechnology
Address:
Gembloux, Namur, Belgium
Country:
Belgium
Website Url:
http://www.erc-immunotherapy.com
Status:
Active
Contact:
+32 81 72 86 10
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
NovaRx
NovaRx Corporation is a clinical-stage biopharmaceutical company.
Official Site Inspections
http://www.erc-immunotherapy.com
- Host name: 206.81.12.176
- IP address: 206.81.12.176
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047